Published in Acta Pharmacol Sin on February 04, 2013
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Retracted Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet (2003) 7.69
An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levels. Clin Chim Acta (1959) 5.06
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation (1992) 3.56
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension (1992) 3.14
Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation (2003) 3.01
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation (2006) 2.67
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res (2003) 2.50
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. Nephrol Dial Transplant (2002) 2.41
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
"Living high-training low": effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol (1985) (1997) 2.17
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res (1998) 2.16
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest (1990) 2.07
Human gene for physical performance. Nature (1998) 1.78
Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) (1999) 1.61
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
"Living high-training low" altitude training improves sea level performance in male and female elite runners. J Appl Physiol (1985) (2001) 1.49
Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension (2005) 1.46
Aerobic capacity in patients entering cardiac rehabilitation. Circulation (2006) 1.42
Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol (2001) 1.18
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol (2001) 1.14
Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol Heart Circ Physiol (2000) 1.11
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol (2003) 1.09
Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J Biol Chem (1993) 1.07
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation (1995) 1.05
Exercise-induced cardiac hypertrophy is associated with an increased myocardial compliance. J Appl Physiol (1985) (1995) 0.94
Current trends in altitude training. Sports Med (2001) 0.94
Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans. Life Sci (2000) 0.92
Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy (2002) 0.91
Localization of angiotensin converting enzyme in rat heart. Circ Res (1991) 0.88
Physiological effects of intermittent hypoxia. High Alt Med Biol (2000) 0.86
The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press (1994) 0.85
Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol (1995) 0.85
The renin-angiotensin system in left ventricular remodeling. Am J Cardiol (1996) 0.84
Kininase II-type enzymes. Their putative role in muscle energy metabolism. Diabetes (1996) 0.84
Effects of escin on acute inflammation and the immune system in mice. Pharmacol Rep (2009) 0.83
ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int (2006) 0.81
Inhibition of paracrine angiotensin-converting enzyme in vivo: effects on interstitial glucose and lactate concentrations in human skeletal muscle. Eur J Clin Invest (1997) 0.79
Intrinsic angiotensin-generating system: its tissue specific functions and clinical implications. Panminerva Med (2002) 0.79
The effect of "living high-training low" on physical performance in rats. Int J Biometeorol (2000) 0.78
Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction. Circulation (1988) 0.78
[Changes in the systemic hemodynamics and the vascular bed of the skeletal muscles in rats adapted to hypoxia]. Fiziol Zh SSSR Im I M Sechenova (1991) 0.77
Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci U S A (2004) 2.02
Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension (2008) 1.94
Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol (2005) 1.31
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol (2004) 1.23
ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin Sci (Lond) (2007) 1.20
Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts. J Biol Chem (2003) 1.10
PKCα mediates acetylcholine-induced activation of TRPV4-dependent calcium influx in endothelial cells. Am J Physiol Heart Circ Physiol (2011) 1.09
Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol (2002) 1.08
Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ Res (2012) 1.05
Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling? J Mol Cell Cardiol (2009) 1.02
TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol (2012) 0.98
Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling. J Mol Cell Cardiol (2008) 0.97
Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels. Am J Physiol Heart Circ Physiol (2012) 0.90
Calcium signaling in excystation of the early diverging eukaryote, Giardia lamblia. J Biol Chem (2002) 0.88
Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. J Nutr Biochem (2012) 0.85
Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium. Am J Physiol Endocrinol Metab (2009) 0.84
Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts. Can J Physiol Pharmacol (2014) 0.83
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Invest New Drugs (2009) 0.82
A TRP to cardiac fibroblast differentiation. Channels (Austin) (2013) 0.81
Endothelin-mediated in vivo pressor responses following TRPV1 activation. Am J Physiol Heart Circ Physiol (2011) 0.81
Beta-adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure. Am J Physiol Lung Cell Mol Physiol (2009) 0.80
Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction. Am J Physiol Heart Circ Physiol (2014) 0.78
Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response. Mol Carcinog (2011) 0.78
Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells. Acta Pharmacol Sin (2005) 0.75
Injury models to study cardiac remodeling in the mouse: myocardial infarction and ischemia-reperfusion. Methods Mol Biol (2013) 0.75
[Effect of gardenin on gene expression profile in brain of rats with focal cerebral ischemia]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2005) 0.75